https://pharminent.com/ivonescimab-beats-keytruda-on-survival-in-china-only-trial-as-its-global-study-stumbles/ 2026-09-03T20:06:24Z Pharminent en Ivonescimab Beats Keytruda on Survival in China-Only Trial as Its Global Study Stumbles 2026-09-03T20:06:21Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-september-3-2026/ 2026-09-03T17:11:06Z Pharminent en Strategic News Watch • September 3, 2026 2026-09-03T17:11:04Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-september-2-2026/ 2026-09-03T17:03:46Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • September 2, 2026 2026-09-03T17:03:43Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-september-2-2026/ 2026-09-03T17:00:44Z Pharminent en Manufacturing Intelligence • Weekly Digest • September 2, 2026 2026-09-03T17:00:42Z Blog https://pharminent.com/boehringer-signs-ai-drug-discovery-deal-with-owkin/ 2026-09-03T18:50:29Z Pharminent en Boehringer signs AI drug discovery deal with Owkin 2026-09-03T09:12:00Z Blog https://pharminent.com/novartis-signs-3-2bn-drug-delivery-deal-with-alteogen/ 2026-09-03T18:50:17Z Pharminent en Novartis signs $3.2bn drug delivery deal with Alteogen 2026-09-03T08:37:52Z Blog https://pharminent.com/uk-suspends-amgens-tavneos-for-new-patients-as-a-data-integrity-cascade-spreads-across-three-regulators/ 2026-09-02T20:11:17Z Pharminent en UK Suspends Amgen's Tavneos for New Patients as a Data-Integrity Cascade Spreads Across Three Regulators 2026-09-02T20:11:17Z Blog https://pharminent.com/autoimmune-car-t-faces-tough-questions-after-novartis-bristol-myers-study-halts/ 2026-09-03T17:51:19Z Pharminent en Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts 2026-09-02T16:32:00Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-september-2-2026/ 2026-09-02T16:08:42Z Pharminent en Strategic News Watch • September 2, 2026 2026-09-02T16:02:37Z Blog https://pharminent.com/tavneos-no-longer-available-for-new-patients-in-uk-as-amgen-awaits-fda-hearing/ 2026-09-02T23:30:14Z Pharminent en Tavneos no longer available for new patients in UK as Amgen awaits FDA hearing 2026-09-02T11:38:48Z Blog https://pharminent.com/ono-pharmaceutical-joins-forces-with-aitia-for-drug-discovery-in-neurology/ 2026-09-02T23:32:19Z Pharminent en Ono Pharmaceutical joins forces with Aitia for drug discovery in neurology 2026-09-02T09:33:16Z Blog https://pharminent.com/us-puts-125m-into-personalised-rna-therapy-production/ 2026-09-02T23:36:42Z Pharminent en US puts $125m into personalised RNA therapy production 2026-09-02T08:56:33Z Blog https://pharminent.com/takeda-and-weave-bio-collaborate-on-ai-driven-automation-in-drug-development-2/ 2026-09-02T23:31:59Z Pharminent en Takeda and Weave Bio collaborate on AI-driven automation in drug development 2026-09-02T08:50:05Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-september-1-2026/ 2026-09-02T00:04:21Z Pharminent en Oncology Intelligence Digest • September 1, 2026 2026-09-02T00:04:20Z Blog https://pharminent.com/novartis-posts-phase-3-ms-win-and-halts-eight-autoimmune-car-t-trials-in-the-same-week/ 2026-09-01T19:36:51Z Pharminent en Novartis Posts Phase 3 MS Win and Halts Eight Autoimmune CAR-T Trials 2026-09-01T19:31:31Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-september-1-2026/ 2026-09-01T16:54:22Z Pharminent en Strategic News Watch • September 1, 2026 2026-09-01T16:54:20Z Blog https://pharminent.com/mid-cap-biotechs-join-trumps-latest-round-of-drug-pricing-deals/ 2026-09-02T23:33:28Z Pharminent en Mid-cap biotechs join Trump's latest round of drug pricing deals 2026-09-01T16:14:00Z Blog https://pharminent.com/novartis-says-ms-pill-succeeds-in-two-large-studies/ 2026-09-02T23:35:41Z Pharminent en Novartis says MS pill succeeds in two large studies 2026-09-01T15:58:00Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-august-31-2026/ 2026-09-01T13:06:01Z Pharminent en Rare Disease & Gene Therapy Digest • August 31, 2026 2026-09-01T13:05:58Z Blog